Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Opinion in Supportive and Palliative Care

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/SPC.0000000000000202PMID 26986508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.

  2016cited by this paper
• Chemotherapy-induced gut toxicity and pain: involvement of TLRs

  2016cited by this paper
• Poly(ADP-ribose) polymerase activation induces high mobility group box 1 release from proximal tubular cells during cisplatin nephrotoxicity.

  2016cited by this paper
• Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids

  2015cited by this paper
• Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.

  2015cited by this paper
• Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model

  2015cited by this paper
• Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

  2015cited by this paper
• The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4

  2015cited by this paper
• Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.

  2015cited by this paper
• Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

  2015cited by this paper
• Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway.

  2015cited by this paper
• Control of adaptive immunity by the innate immune system

  2015cited by this paper
• Mucositis: pathobiology and management

  2015cited by this paper
• Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks

  2015cited by this paper
• Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage

  2015cited by this paper
• Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study

  2015cited by this paper
• TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine

  2015cited by this paper
• Chemotherapy‐driven dysbiosis in the intestinal microbiome

  2015cited by this paper
• The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis

  2015cited by this paper
• Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4.

  2014cited by this paper
• Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

  2014cited by this paper
• IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice

  2014cited by this paper
• The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration.

  2014cited by this paper
• Lipopolysaccharide Induces Inflammatory Hyperalgesia Triggering a TLR4/MyD88-Dependent Cytokine Cascade in the Mice Paw

  2014cited by this paper
• Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications

  2014cited by this paper
• Regulation of the immune system by the resident intestinal bacteria.

  2014cited by this paper
• MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

  2014cited by this paper
• Role of Constitutive Androstane Receptor in Toll-Like Receptor-Mediated Regulation of Gene Expression of Hepatic Drug-Metabolizing Enzymes and Transporters

  2014cited by this paper
• Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia

  2014cited by this paper
• Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients

  2014cited by this paper
• Spinal HMGB1 induces TLR4‐mediated long‐lasting hypersensitivity and glial activation and regulates pain‐like behavior in experimental arthritis

  2014cited by this paper
• Xenobiotic Pregnane X Receptor (PXR) Regulates Innate Immunity via Activation of NLRP3 Inflammasome in Vascular Endothelial Cells*

  2014cited by this paper
• Risk of Repeated Moraxella catarrhalis Colonization Is Increased in Children With Toll-like Receptor 4 Asp299Gly Polymorphism

  2013cited by this paper
• P-glycoprotein ABCB1: a major player in drug handling by mammals.

  2013cited by this paper
• The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

  2013cited by this paper
• Microbiota and innate immunity in intestinal inflammation and neoplasia

  2013cited by this paper
• Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

  2013cited by this paper
• Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia

  2013cited by this paper
• Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis

  2013cited by this paper
• Loss of TLR2 Worsens Spontaneous Colitis in MDR1A Deficiency through Commensally Induced Pyroptosis

  2013cited by this paper
• Bacterial inactivation of the anticancer drug doxorubicin.

  2012cited by this paper
• Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists

  2012cited by this paper
• The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.

  2012cited by this paper
• Recognition of Streptococcus pneumoniae by the innate immune system

  2012cited by this paper
• Severity of doxorubicin‐induced small intestinal mucositis is regulated by the TLR‐2 and TLR‐9 pathways

  2012cited by this paper
• Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner

  2011cited by this paper
• Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer.

  2011cited by this paper
• The interaction of gut microbes with host ABC transporters

  2010cited by this paper
• Toll-like receptors in inflammatory bowel diseases: A decade later

  2010cited by this paper
• Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study.

  2010cited by this paper
• Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

  2010cited by this paper
• A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

  2009cited by this paper
• Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis

  2009cited by this paper
• TLR2 Mediates Gap Junctional Intercellular Communication through Connexin-43 in Intestinal Epithelial Barrier Injury*

  2009cited by this paper
• Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia

  2009cited by this paper
• Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency.

  2009cited by this paper
• Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

  2007cited by this paper
• Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

  2007cited by this paper
• Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

  2007cited by this paper
• Intestinal microflora and digestive toxicity of irinotecan in mice.

  2006cited by this paper
• Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases

  2006cited by this paper
• Contributions of mucosal immune cells to methotrexate-induced mucositis.

  2006cited by this paper
• The burdens of cancer therapy

  2004cited by this paper
• Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2–Knockout Mice

  2004cited by this paper
• The pathobiology of mucositis.

  2004cited by this paper
• The pathobiology of mucositis

  2004cited by this paper
• The burdens of cancer therapy

  2003cited by this paper
• Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer.

  2003cited by this paper
• Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide.

  2002cited by this paper
• Mouse Toll-like Receptor 4·MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol*

  2000cited by this paper
• Molecular Identification of GemellaSpecies from Three Patients with Endocarditis

  1998cited by this paper
• Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets.

  1997cited by this paper
• Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.

  1993cited by this paper

• Multi-Target Protective Effects of Sanghuangporus sanghuang Against 5-Fluorouracil-Induced Intestinal Injury Through Suppression of Inflammation, Oxidative Stress, Epitheli-Al-Mesenchymal Transition, and Tight Junction

  2025cites this paper
• Sorafenib induces intestinal toxicity by disturbing gut microbiota and activating the LPS/TLR4/NF-κB signaling pathway in mice.

  2025cites this paper
• Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy

  2024cites this paper
• Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition).

  2024cites this paper
• Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework

  2024cites this paper
• Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway

  2023cites this paper
• The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity

  2023cites this paper
• Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation

  2023cites this paper
• Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

  2023cites this paper
• The Role of the Innate Immune Response in Oral Mucositis Pathogenesis

  2023cites this paper
• Microbiota milieu and mechanisms of intestinal Toll Like Receptors (TLRs) involved in chemotherapy induced mucositis

  2022cites this paper
• Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV

  2022cites this paper
• Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity

  2022influential citation
• The impact of oral health education on the incidence and severity of oral mucositis in pediatric cancer patients: a systematic review and meta-analysis

  2022cites this paper
• Roles of Toll-Like Receptors in Radiotherapy- and Chemotherapy-Induced Oral Mucositis: A Concise Review

  2022influential citation
• Lactoferrin modulates gut microbiota and Toll-like receptors (TLRs) in mice with dysbiosis induced by antibiotics.

  2022cites this paper
• The science of mucositis

  2022cites this paper
• in Gut Microbiota Potentiates the Effect of Immune Checkpoint Therapy against Cancers

  2022cites this paper
• Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model

  2022cites this paper
• Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity

  2022cites this paper
• Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways

  2021cites this paper
• Intake of Lactobacillus delbrueckii (pExu:hsp65) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis

  2021cites this paper
• FTIR microspectroscopic investigation of Lactobacillus paracasei apoptosis induced by cisplatin.

  2021cites this paper
• Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

  2021cites this paper
• Connecting the dots: Targeting the microbiome in drug toxicity

  2021influential citation
• TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea

  2021cites this paper
• Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?

  2021cites this paper
• Mucositis

  2021cites this paper
• Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.

  2020cites this paper
• The Lactobacillus brevis 47 f Strain Protects the Murine Intestine from Enteropathy Induced by 5-Fluorouracil

  2020cites this paper
• Effect of Lactobacillus plantarum ACTT 8014 on 5-fluorouracil induced intestinal mucositis in Wistar rats

  2020influential citation
• The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer

  2019cites this paper
• Octreotide treatment of cancer chemoradiotherapy-induced diarrhoea: a meta-analysis of randomized controlled trials

  2019cites this paper
• The pathogenesis of mucositis: updated perspectives and emerging targets.

  2019cites this paper
• Thirty Years of Lactobacillus rhamnosus GG: A Review.

  2019cites this paper
• Immunomodulatory Protein Hydrolysates and Their Application

  2018cites this paper
• Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis

  2018cites this paper
• Clinical progress on moxibustion in preventing and treating adverse effects of surgery or chemoradiotherapy for breast cancer

  2018cites this paper
• Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy

  2018cites this paper
• Probiotics and mucositis

  2018cites this paper
• Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats

  2017cites this paper
• May cannabinoids prevent the development of chemotherapy‐induced diarrhea and intestinal mucositis? Experimental study in the rat

  2017cites this paper
• Probiotic Bifidobacterium bifidum G9‐1 attenuates 5‐fluorouracil‐induced intestinal mucositis in mice via suppression of dysbiosis‐related secondary inflammatory responses

  2017cites this paper
• Chemotherapeutic treatment reduces circulating levels of surfactant protein‐D in children with acute lymphoblastic leukemia

  2017cites this paper
• Advances in the understanding and management of mucositis during stem cell transplantation

  2017cites this paper
• Microbiota: a key orchestrator of cancer therapy

  2017cites this paper
• t i

  year unknowncites this paper